Overview
Boston Scientific's neuromodulation portfolio spans spinal cord stimulation, deep brain stimulation, and sacral neuromodulation for pain, movement disorders, and pelvic conditions. Their Vercise Genus DBS system and WaveWriter Alpha SCS platform represent the company's latest advances in closed-loop, personalized neural therapy.
More in Neuromodulation
Latest industry news
Cala Health Launches Next-Generation TAPS Therapy Wearable Nationwide for Tremor and Parkinson's Patients
2026-10-11 · Product
A New Neurotech Startup Launches to Challenge Sam Altman's Merge Labs in the BCI Race
2026-10-10 · Industry
Butterfly Network Teams Up With Bridge Neurotech to Chase Ultrasound-Based Brain-Computer Interfaces
2026-10-09 · Industry
Paradromics Hits Four-Year Mark for Stable Neural Recording in Landmark BCI Durability Milestone
2026-10-08 · Research
Company details
Category
⚡ Neuromodulation
Location
Marlborough, MA, USA
Funding
NYSE: BSX
Listed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →